Hualan Biological (002007): Interim results slightly higher than expected long-term growth

Hualan Biological (002007): Interim results slightly higher than expected long-term growth Investment Highlights: Maintain Overweight rating. Taking into account that the blood products industry is still in the recovery stage, we raise the company’s forecast for EPS to 2019-2021. 01/1. 17/1. 34 yuan (was 1). 01/1. 13/1. 25 yuan), the current industry competition company PE […]

Zhongsheng Pharmaceutical (002317) company review report (revised edition): waiting for the clinical effect of chloroquine phosphate tablets

Zhongsheng Pharmaceutical (002317) company review report (revised edition): waiting for the clinical effect of chloroquine phosphate tablets Note: The red text is changed from “According to” to “Understanding from the listed company”. The statement of the switch is not accurate. Only the source of the data is specified in the working manuscript. Please refer to […]

Sino-Singapore Group (601512): The model model of Sino-Singapore park companies is highly replicable

Sino-Singapore Group (601512): The model model of Sino-Singapore park companies is highly replicable Investment points: Sino-Singapore joint venture large-scale park development company. The company takes the development and operation of the park as the main section, and the overall supporting industry and green as the two-wing support section. At present, the group has more than […]

Ruichuang Micro-nano (688002) New Share Issuance and Listing Pricing Report: A Domestic Leading Company in Infrared Thermal Imaging

Ruichuang Micro-nano (688002) New Share Issuance and Listing Pricing Report: A Domestic Leading Company in Infrared Thermal Imaging The company is a leading domestic infrared thermal imaging supplier. It is an integrated circuit chip company specializing in the development of uncooled infrared thermal imaging and MEMS sensing technology. It is committed to the design and […]

Zoomlion (000157): Significant achievements in focus strategy and expected development strategy

Zoomlion (000157): Significant achievements in focus strategy and expected development strategy Core point of view: The company released three quarterly reports and achieved operating income of 317 in the first three quarters. 550,000 yuan (currency, Renminbi), achieving net profit attributable to mother 34. 800,000 yuan, an increase of 167 in ten years. 08%, in line […]

Adisseo (600299) Quarterly Commentary: Annual Growth in Performance Continues to Advance BANG Plan

Adisseo (600299) Quarterly Commentary: Annual Growth in Performance Continues to Advance “BANG” Plan Event: The company released the third quarter report of 2019, and achieved revenue of 83 in the first three quarters. 1.2 billion US dollars, a year-on-year decrease of 2%, net profit attributed to mother 8. USD 1.2 billion, an increase of 14% […]

Zoomlion (000157) company dynamic comment: the industry’s high business performance and strong growth deepen the advantages of intelligent manufacturing technology is significant

Zoomlion (000157) company dynamic comment: the industry’s high business performance and strong growth deepen the advantages of intelligent manufacturing technology is significant Event: On August 31, 2019, the company released its semi-annual report for 2019, and realized revenue of 222 in the first half of 2019. 62 ppm, an increase of 51 in ten years. […]